SEC Form D · filed September 2, 2016
HEMISPHERX BIOPHARMA INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Wayne K. Springate · Philadelphia, PAExecThomas W. Horner · Atlanta, GAExec · DirectorChang K. Kim · Dania Beach, FLExecJulia S. Pence · Newport Beach, CAExecStewart W. Appelrouth · Philadelphia, PADirectorThomas K. Equels · Philadelphia, PAExec · DirectorJeffrey S. Meister · Newport Beach, CADirectorDenise A. Archer · Grand Cayman, Cayman IslandsExecAdriel Lares · San Francisco, CAExecAdam K. Pascale · Philadelphia, PAExecArnold Oronsky · BOSTON, MAExec · DirectorLalitendu K. Panda · Dania Beach, FLDirectorNicholas D. Tannura · Newport Beach, CADirectorCraig A. Leupold · Newport Beach, CADirectorRobert N. Longo · Atlanta, GAExecRandall M. Stevens · BOSTON, MAExecMark Hanson · Chicago, ILDirectorWilliam K. Mitchell · Philadelphia, PADirectorDavid K. Strayer · Philadelphia, PAExecDavid A. Witkin · Redondo Beach, CADirectorPeter W. Rodino · Philadelphia, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗